作为潜在的抗癌,抗菌,抗氧化剂和其分子对接研究的Tridax procumbens L. 的新素
Varsharani V Ingole1,2, Pravin C Mhaske3, Siraj B Shaikh4
1Department of Chemistry, PES's Modern College of Arts, Science and Commerce, Pune, India.
Natural product research
|April 23, 2025
概括
来自T. procumbens L.的一种新的库马林化合物在实验室测试中显示出显著的抗癌和抗氧化特性. 需要进一步的研究来确认其作为治疗剂的潜力.
科学领域:
- 植物化学 植物化学
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在T. procumbens L.的空气部分是生物活性化合物的来源.
- 库马林是一种具有多种生物活性的自然产品.
研究的目的:
- 从T. procumbens和L. procumbens中分离和鉴定一种新的氨酸.
- 评估隔离库马林的细胞毒性,抗微生物和抗氧化活性.
主要方法:
- 使用甲醇提取的植物化学研究.
- 通过二氧化柱色谱进行隔离.
- 使用光谱方法阐明结构.
- 细胞毒性通过MTT测定进行评估.
- 通过MIC值确定的抗菌活性.
- 使用IC50值评估的抗氧化活性.
- 在 silico 研究支持抗微生物发现.
主要成果:
- 一种新型库马林化合物被成功分离和鉴定出来.
- 库马林对MCF-7 (IC50 = 4.92 μg/mL) 和MDA-MB-249 (IC50 = 5.99 μg/mL) 细胞系表现出显著的细胞毒性.
- 观察到强烈的抗氧化活性,IC50为1.36μg/mL.
- 针对S. aureus (MIC = 125μg/mL) 和P. aeruginosa (MIC = 31.5μg/mL) 发现了抗菌活性.
- 在分析证实了观察到的抗微生物作用.
结论:
- 来自T. procumbens L.的新型库马林具有有前途的细胞毒性,抗氧化剂和抗菌性质.
- 该化合物值得进一步研究,因为它是癌症和传染病的潜在治疗剂.
- 需要进行额外的研究才能完全确定其疗效和安全性.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
545
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
545
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship
2.0K
Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
2.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
473
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
473
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
745
Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
The direct-acting...
745
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
997
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
997
Drug Binding to Blood Components
64
When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are...
64


